Pomdoctor six-month net loss widens to RMB 238.17 million; net revenues rise 6% to RMB 185 million
Bitget2026/09/29 20:04- Pomdoctor posted a net loss of RMB 238.17 million for the six months ended June 30, 2026.
- Net revenues rose 6% to RMB 185 million in the six months ended June 30, 2026.
- Loss from operations widened to RMB 233.33 million in the period.
- Sales and marketing expenses surged to RMB 76.4 million, while research and development expenses jumped to RMB 106.27 million.
- It reported a going-concern warning, citing a RMB 137.2 million working capital deficit at June 30, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
OGE Energy schedules quarterly earnings conference call and business update
Saia to release quarterly financial results before market open, host conference call
JPMorgan Reveals the Critical Price Level for Bitcoin Miners

Altman: Safety comes first, no IPO timetable, postponing the release of GPT-6.1 Astra out of extreme caution
OpenAI CEO Altman stated that the IPO may only be considered after the company gains a clearer understanding of how to safely manage the "next-level AI." The delay in launching GPT-6.1 Astra is because the model did not meet some of the company’s evaluation criteria for safety; this decision was made "out of an abundance of caution" rather than due to any major incident. He also noted that Nvidia’s safety systems for AI are not a "complete solution;" AI is more of a scientific problem than an engineering one.